P. Pan

发表

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

C. Divino, J. Kao, M. Meseck, 2009, Cancer research.

Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells.

C. Divino, T. Takai, Ge Ma, 2011, Immunity.

T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer

S. Thung, O. Martinet, Y. Zang, 2002, Gene Therapy.

Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

C. Divino, D. Levy, Qingsheng Li, 2006, Cancer research.

Positive Regulation of Interleukin-4-mediated Proliferation by the SH2-containing Inositol-5′-phosphatase*

N. Danial, J. Cambier, K. Coggeshall, 2000, The Journal of Biological Chemistry.

OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases.

M. Meseck, Shu-Hsia Chen, Y. Zang, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

Sathish Kumar Mungamuri, Bin Zhang, R. Flavell, 2018, The Journal of clinical investigation.

Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy

C. Divino, J. Kao, Ge Ma, 2015, Clinical Cancer Research.

Virus‐Mimic mRNA Vaccine for Cancer Treatment

Haifa Shen, J. Mai, Shu-Hsia Chen, 2021, Advanced therapeutics.

Immune cells: more than simple carriers for systemic delivery of oncolytic viruses

Shu-Hsia Chen, P. Pan, S. Eisenstein, 2014, Oncolytic virotherapy.

NK and CD8+ T cell‐mediated eradication of poorly immunogenic B16‐F10 melanoma by the combined action of IL‐12 gene therapy and 4‐1BB costimulation

Qingsheng Li, Shu-Hsia Chen, P. Pan, 2004, International journal of cancer.

Myeloid-derived suppressor cells as a Trojan horse

Shu-Hsia Chen, P. Pan, Hui-ming Chen, 2013, Oncoimmunology.

Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity

Qingsheng Li, Shu-Hsia Chen, P. Pan, 2004, Cancer Research.

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function.

C. Divino, Shu-Hsia Chen, Bingjiao Yin, 2008, Blood.

Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.

Shu-Hsia Chen, P. Pan, Jilu Zhang, 2021, Cellular immunology.

In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery

Y. Li, Qingsheng Li, S. Thung, 2003, Cancer Immunology, Immunotherapy.

4-1BB Activation in the Combination Therapy of IL-12 and Synergism Cells: Mechanisms Underlying the Regulation of Dendritic Cell Function by NK

Qingsheng Li, Shu-Hsia Chen, P. Pan, 2004 .

Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study

G. Calin, V. Cristini, B. Ozpolat, 2022, Cell Death & Disease.

Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis

V. Singh, C. Jagannath, Shu-Hsia Chen, 2022, Frontiers in Immunology.

Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy.

C. Divino, K. Briley-Saebo, M. Meseck, 2013, Cancer research.

A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer

Jenny C. Chang, L. Venta, W. Qian, 2021, Science Translational Medicine.

Myeloid-Derived Suppressive Cells and Their Regulatory Mechanisms in Cancer

Ge Ma, Shu-Hsia Chen, P. Pan, 2012 .

Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B

Sathish Kumar Mungamuri, Yi Luan, M. Feldmann, 2018, The Journal of Immunology.

Immunoreceptor Tyrosine-Based Inhibitory Motif of the IL-4 Receptor Associates with SH2-Containing Phosphatases and Regulates IL-4-Induced Proliferation1

M. Kashiwada, P. Rothman, C. Giallourakis, 2001, The Journal of Immunology.

IL-4 receptor mutations.

P. Rothman, P. Pan, 1999, Current opinion in immunology.

factor function myeloid-derived suppressor cell development by blockade of stem-cell Reversion of immune tolerance in advanced malignancy: modulation of

C. Divino, Bingjiao Yin, George X. Wang, 2013 .

Reversion of immune tolerance in advanced malignancy : modulation of myeloid derived suppressor cell development by blockade of SCF function

C. Divino, Shu-Hsia Chen, Bingjiao Yin, 2007 .

LILRB receptor-mediated regulation of myeloid cell maturation and function

Shu-Hsia Chen, P. Pan, W. van der Touw, 2017, Cancer Immunology, Immunotherapy.

Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models

C. Divino, Ge Ma, Shu-Hsia Chen, 2010, The Journal of Immunology.

Leukocyte immunoglobulin‐like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies

X. Li, Shu-Hsia Chen, Sunny Mai, 2017, Journal of leukocyte biology.

Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune Microenvironment

Shu-Hsia Chen, Sunny Mai, P. Pan, 2020, Frontiers in Immunology.

Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6

Jenny C. Chang, W. Qian, A. Chan, 2022, NPJ breast cancer.

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

C. Divino, Ge Ma, Shu-Hsia Chen, 2010, Cancer research.

Advancements in immune tolerance.

Shu-Hsia Chen, Zuping Zhou, P. Pan, 2008, Advanced drug delivery reviews.

Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling

R. Sidman, S. Curley, V. Cristini, 2021, medRxiv.

The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.

Ge Ma, Shu-Hsia Chen, D. Raulet, 2019, Leukemia.

IL-4 signaling is regulated through the recruitment of phosphatases, kinases, and SOCS proteins to the receptor complex.

M. Kashiwada, P. Rothman, C. Giallourakis, 1999, Cold Spring Harbor symposia on quantitative biology.

Regulation of Dendritic Cell Function by NK Cells: Mechanisms Underlying the Synergism in the Combination Therapy of IL-12 and 4-1BB Activation1

Qingsheng Li, Shu-Hsia Chen, P. Pan, 2004, The Journal of Immunology.

Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6

Jenny C. Chang, W. Qian, A. Chan, 2022, npj Breast Cancer.

Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles

C. Coarfa, Shu-Hsia Chen, Yitian Xu, 2022, Cancer research communications.

Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism

Shu-Hsia Chen, Lu‐Hai Wang, P. Pan, 2021, Cancer Immunology, Immunotherapy.

Development and Function of Myeloid‐Derived Suppressor Cells Generated From Mouse Embryonic and Hematopoietic Stem Cells

C. Divino, G. Keller, Ge Ma, 2010, Stem cells.

Polarization and reprogramming of myeloid-derived suppressor cells.

Ge Ma, Shu-Hsia Chen, P. Pan, 2013, Journal of molecular cell biology.